Pmv Capital Surpluse from 2010 to 2025
| PMVP Stock | USD 1.43 0.02 1.42% |
Capital Surpluse | First Reported 2010-12-31 | Previous Quarter 560.6 M | Current Value 525.4 M | Quarterly Volatility 25.8 M |
Check Pmv Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pmv Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 4.5 K, Net Interest Income of 11.8 M or Interest Income of 11.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.62. Pmv financial statements analysis is a perfect complement when working with Pmv Pharmaceuticals Valuation or Volatility modules.
Pmv | Capital Surpluse |
Latest Pmv Pharmaceuticals' Capital Surpluse Growth Pattern
Below is the plot of the Capital Surpluse of Pmv Pharmaceuticals over the last few years. It is Pmv Pharmaceuticals' Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pmv Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Capital Surpluse | 10 Years Trend |
|
Capital Surpluse |
| Timeline |
Pmv Capital Surpluse Regression Statistics
| Arithmetic Mean | 481,027,421 | |
| Geometric Mean | 480,424,005 | |
| Coefficient Of Variation | 5.37 | |
| Mean Deviation | 17,119,381 | |
| Median | 469,001,000 | |
| Standard Deviation | 25,824,570 | |
| Sample Variance | 666.9T | |
| Range | 91.6M | |
| R-Value | 0.67 | |
| Mean Square Error | 397T | |
| R-Squared | 0.44 | |
| Significance | 0 | |
| Slope | 3,616,191 | |
| Total Sum of Squares | 10003.6T |
Pmv Capital Surpluse History
About Pmv Pharmaceuticals Financial Statements
Pmv Pharmaceuticals shareholders use historical fundamental indicators, such as Capital Surpluse, to determine how well the company is positioned to perform in the future. Although Pmv Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Pmv Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Pmv Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Capital Surpluse | 560.6 M | 525.4 M |
Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.